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LETTER TO THE EDITOR
Early Diagnosis Remains the Most Reliable Way
to Cure Chidren With Melanoma: Response
We thank Drs. Aldo and Ferrari for sharing their clinical
experience with pediatric melanoma. They make several
important points in their letter which we feel require
emphasis. The clinical characteristics of pediatric mela-
nomas often do not follow the ‘‘ABCD rule’’ classically
seen in adult melanomas. In fact, childhood melanomas
are frequently amelanotic and often lack particularly
worrisome features, characteristics that may contribute to
delays in diagnosis, resulting in more advanced disease
and worse prognosis. These atypical features associated
with pediatric melanomas therefore make it difficult to
have a well-founded clinical suspicion of malignancy. It is
precisely because the diagnosis of pediatric melanoma can
be difficult that prompt referral to a dermatologist or
pediatric oncologist with experience in the diagnosis and
management of pediatric melanoma is warranted for any
suspected melanocytic skin lesion. We certainly agree that
the avoidance of patient/parent stress and conservation of
medical resources are worthwhile goals. However,
because early detection offers the best chance of cure for
melanoma patients, we would be concerned about a
‘‘short-term’’ observation period, and would consider
careful and limited excisional biopsy of suspected
melanocytic lesions in children sooner rather than later.
Together with our report, the observations of Drs. Aldo
and Ferrari should reinforce to primary caregivers and
parents that the incidence of malignant melanoma is
increasing in Western countries, and that these tumors do
occur in children who are not otherwise at risk.
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